Seagen to Host Conference Call and Webcast Discussion of Fourth Quarter and Full Year 2021 Financial Results on February 9, 2022

Seagen Inc. (Nasdaq: SGEN) today announced that it will report its fourth quarter and full year 2021 financial results on Wednesday, February 9, 2022 after the close of U.S. financial markets.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Tuesday, January 18, 2022
Information
Tags: 
Oncology, Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Seagen, Inc., Webcast, Conference, Twitter, Conference call, Union, Company, Pharmaceutical industry, Broadcasting
Geotags: 
WASHINGTON, SWITZERLAND, SEATTLE, CALIFORNIA, CANADA
⚠generated by AI ↴
Summary
Key Points: 
  • Seagen Inc. (Nasdaq: SGEN) today announced that it will report its fourth quarter and full year 2021 financial results on Wednesday, February 9, 2022 after the close of U.S. financial markets.
  • Following the announcement, Company management will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the results and provide a business update.
  • Conference call and webcast information:
    Webcast with slides can be accessed at investor.seagen.com .
  • Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union.


Seagen Inc. (Nasdaq: SGEN) today announced that it will report its fourth quarter and full year 2021 financial results on Wednesday, February 9, 2022 after the close of U.S. financial markets. Following the announcement, Company management will host a conference call and webcast at 4:30 p.m. Eastern Time to discuss the results and provide a business update.

Conference call and webcast information:

  • Telephone 844-763-8274 (U.S.) or +1 412-717-9224 (international); conference ID 10163004
  • Webcast with slides can be accessed at investor.seagen.com. A webcast replay will be archived on the Company’s website.

About Seagen

Seagen is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people’s lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union. For more information on the company’s marketed products and robust pipeline, visit www.seagen.com and follow @SeagenGlobal on Twitter.

Copyright: 
Copyright Business Wire 2022